Gerrit A. Van Essen

Amersfoort, UT, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Evaluating the cost-effectiveness of adjuvanted influenza vaccine in the older adult population in the Netherlands.

Evaluating the cost-effectiveness of adjuvanted influenza vaccine in the older adult population in the Netherlands.

Journal: Human vaccines & immunotherapeutics

Published: June 29, 2026

Vaccination policies for healthcare personnel in Europe, 2026.

Vaccination policies for healthcare personnel in Europe, 2026.

Journal: Vaccine

Published: May 11, 2026

Infectious diseases, infection control, vaccines and long-term care: an European interdisciplinary Council on ageing consensus document.

Infectious diseases, infection control, vaccines and long-term care: an European interdisciplinary Council on ageing consensus document.

Journal: Aging clinical and experimental research

Published: October 03, 2025

Disparities in Seasonal Influenza Vaccination in Europe.

Disparities in Seasonal Influenza Vaccination in Europe.

Journal: Immunity, inflammation and disease

Published: October 24, 2024

Synthesizing and assessing influenza vaccine evidence: Strengths and limitations of the recent ECDC report on the effectiveness of new and enhanced influenza vaccines. Communication on: the "European Centre for Disease Prevention and Control. Systematic review update on the efficacy, effectiveness and safety of newer and enhanced seasonal influenza vaccines for the prevention of laboratory confirmed influenza in individuals aged 18 years and over. Stockholm: ECDC; 2024".

Synthesizing and assessing influenza vaccine evidence: Strengths and limitations of the recent ECDC report on the effectiveness of new and enhanced influenza vaccines. Communication on: the "European Centre for Disease Prevention and Control. Systematic review update on the efficacy, effectiveness and safety of newer and enhanced seasonal influenza vaccines for the prevention of laboratory confirmed influenza in individuals aged 18 years and over. Stockholm: ECDC; 2024".

Journal: Germs

Published: August 23, 2024

The influenza landscape and vaccination coverage in older adults during the SARS-Cov-2 pandemic: data from Several European Countries and Israel.

The influenza landscape and vaccination coverage in older adults during the SARS-Cov-2 pandemic: data from Several European Countries and Israel.

Journal: Expert review of respiratory medicine

Published: April 23, 2024

Influenza vaccination: the Netherlands Health Council missed opportunities

Influenza vaccination: the Netherlands Health Council missed opportunities

Journal: Nederlands tijdschrift voor geneeskunde

Published: December 02, 2021

Identifying adults with acute rhinosinusitis in primary care that benefit most from antibiotics: protocol of an individual patient data meta-analysis using multivariable risk prediction modelling.

Identifying adults with acute rhinosinusitis in primary care that benefit most from antibiotics: protocol of an individual patient data meta-analysis using multivariable risk prediction modelling.

Journal: BMJ open

Published: July 02, 2021

Vaccination of healthcare personnel in Europe: Update to current policies.

Vaccination of healthcare personnel in Europe: Update to current policies.

Journal: Vaccine

Published: January 04, 2019

Impact of European vaccination policies on seasonal influenza vaccination coverage rates: An update seven years later.

Impact of European vaccination policies on seasonal influenza vaccination coverage rates: An update seven years later.

Journal: Human vaccines & immunotherapeutics

Published: June 21, 2018

Effectiveness and cost-effectiveness of nationwide campaigns for awareness and case finding of hepatitis C targeted at people who inject drugs and the general population in the Netherlands.

Effectiveness and cost-effectiveness of nationwide campaigns for awareness and case finding of hepatitis C targeted at people who inject drugs and the general population in the Netherlands.

Journal: The International journal on drug policy

Published: December 20, 2016

Immunogenicity of AS03-adjuvanted and non-adjuvanted trivalent inactivated influenza vaccines in elderly adults: A Phase 3, randomized trial and post-hoc correlate of protection analysis.

Immunogenicity of AS03-adjuvanted and non-adjuvanted trivalent inactivated influenza vaccines in elderly adults: A Phase 3, randomized trial and post-hoc correlate of protection analysis.

Journal: Human vaccines & immunotherapeutics

Published: October 04, 2016

Showing 1-12 of 22

Last Updated: 09/26/2026